Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 4 Articles
Tags:
cholesterol
,
david-c-steffens
,
depression
,
douglas-r-mcquoid
,
elderly
,
k-ranga-rama-krishnan
,
medication
,
relapse
,
vascular
Description
Description
David C. Steffens, MD, MHS
PSYCHIATRIC COMORBIDITIES
Cholesterol-Lowering Medication and Relapse of Depression
David C. Steffens, MD, MHS, Douglas R. McQuoid, BS, and K. Ranga Rama Krishnan, MB, ChB
Related products
Efficacy of Omega-3 Fatty Acids in Mood Disorders
$
30.00
Add to cart
Details
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Page load link
Go to Top
